home All News open_in_new Full Article

Tratament revoluționar pentru cancerul de sân. Doar cu o pastilă se reduce la jumătate riscul de progresie

Administrarea pastilei experimentale camizestrant a AstraZeneca pacienţilor cu cancer de sân, la primul semn de rezistenţă la terapiile standard, a redus la jumătate riscul de progresie a bolii sau deces.


today 6 d. ago attach_file Science

attach_file Science
attach_file Science
attach_file Sport
attach_file Science
attach_file Economics
attach_file Sport
attach_file Science
attach_file Economics
attach_file Economics
attach_file Science
attach_file Science
attach_file Economics
attach_file Society
attach_file Sport
attach_file Transport
attach_file Economics
attach_file Politics
attach_file Sport
attach_file Science
attach_file Politics


ID: 3127320676
Add Watch Country

arrow_drop_down